Boehringer Ingelheim marks retinal disease push with $327m licensing deal
Boehringer Ingelheim currently does not have any approved therapies for ophthalmic indications, but the company is looking to change that …
Post
-
-
Accelerating diagnosis and drug development with better managed datasets
Every aspect of science and research is based on data, and across the globe, labs are producing more data than …
-
Novel software solutions can ease transition in an age of clinical supply chain upheaval
The healthcare landscape faces turbulent times. Regulatory pressures, challenges around demand forecasting and an influx of novel therapies are heaping …
-
FDA approves Papzimeos as first therapy for HPV-caused airway disease
The US Food and Drug Administration (FDA) has approved the first treatment for recurrent respiratory papillomatosis (RRP), a rare respiratory …
-
Wegovy becomes first GLP-1RA to gain FDA MASH approval
Danish big pharma Novo Nordisk has been given the go-ahead for its star weight loss drug, Wegovy (semaglutide), in patients …
-
Aquestive signs $75m agreement for launch of Anaphylm
Aquestive Therapeutics has made a strategic funding agreement worth $75m with RTW Investments to support the potential launch of Anaphylm …
-
Sanofi receives orphan status from EMA for rilzabrutinib
Sanofi has received orphan designation from the European Medicines Agency (EMA) for rilzabrutinib, a reversible covalent Bruton’s tyrosine kinase (BTK) …
-
Addressing inefficiencies in clinical trial data management
Data management plays a vital role in the success and reliability of clinical trials by ensuring the integrity, quality and …
-
FDA approves Tonix’s Tonmya to treat fibromyalgia
Tonix Pharmaceuticals has received approval from the US Food and Drug Administration (FDA) for Tonmya (cyclobenzaprine HCl sublingual tablets) to …
-
Sanofi’s Tzield secures MHRA go-ahead for type 1 diabetes
Sanofi-owned Aventis Pharma has received approval for its type 1 diabetes (T1D) drug, Tzield (teplizumab), from the UK Medicines and …
-
Trump targets bolstering of US emergency drug reserve
US President Donald Trump has ordered the bolstering of the country’s Strategic Active Pharmaceutical Ingredients Reserve (SAPIR) with important drugs, …
-
UK pharmacist says Eli Lilly’s Mounjaro price hike a “shock”
Eli Lilly will increase the UK list price of its blockbuster drug Mounjaro (tirzepatide) amid pressure from US President Donald …
-
AI is improving idiopathic pulmonary fibrosis care
Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease characterised by the accumulation of scar tissue in the lungs, leading …
-
CDMO insights podcast series: Our Experience is Your Strength | Episode #4 Commercial Launch
Once a drug receives regulatory approval, the clock starts ticking to get high-quality products packed, shipped, and available on the …
-
Infectious disease screening during substance use disorder treatment increases detection, prevention, and treatment
According to the US Centers for Disease Control and Prevention, substance use disorder (SUD) affects approximately one in six people …
